Found 328 matching trials
Rituximab Plus CHOP With Sargramostim in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma PHASE2 The use of R-CHOP, given every two weeks, will be associated with improveme...
Show More Location
USC Norris Comprehensive Cancer Center
Learn More & Join Trial
A Combination of Acalabrutinib With R-CHOP for Patient Diffuse Large B-cell Lymphoma (DLBCL) PHASE1 Previously untreated CD20 positive diffuse large B-cell lymphoma (DLBCL) re...
Show More Location
Southampton University Hospitals NHS Tust
Learn More & Join Trial
High-dose Chemotherapy With Rituximab for Adults With Aggressive Large B-cell Lymphoma PHASE2 A prospective pilot trial was proposed to patients with DLBCL, with IH or h...
Show More Location
University Hospital
Learn More & Join Trial
Patient Preference for Pegfilgrastim (Neulasta®) Application Forms NA The study aims to compare two application forms (pre-filled syringe and On-...
Show More Learn More & Join Trial
Rituximab in Combination With Glofitamab and Polatuzumab Vedotin in Patients With Previously Untreated Aggressive B-cell Lymphoma Ineligible for R-CHOP PHASE2 In the present trial the chemotherapy- light treatment concept R-Pola-Glo w...
Show More Status
Active Not Recruiting
Location
Uniklinik Innsbruck
Learn More & Join Trial
Abbreviated 3 Cycles of Rituximab Plus CHOP(Cyclophosphamide, Adriamycin, Vincristine, and Prednisolone) Immunochemotherapy in Patients With Completely Excised LocalizedGastrointestinal CD(Cluster of Differentiation Antigen)20(+) Diffuse Large B-cell Lymphoma PHASE2 Phase 2 Study of Abbreviated 3 Cycles of Rituximab plus CHOP (Cyclophospham...
Show More Location
Multiple Locations
Learn More & Join Trial
Multicentre Study to Determine the Cardiotoxicity of R-CHOP Compared to R-COMP in Patients With Diffuse Large B-Cell Lymphoma PHASE2 Diffuse large B-cell lymphoma is the most prevalent subgroup within maligna...
Show More Location
Landeskrankenhaus Feldkirch
Learn More & Join Trial
Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma PHASE2 The purpose of this study is to clarify the impact of rituximab on clinical...
Show More Location
Chonbuk National University Hospital
Learn More & Join Trial
Assessing a ctDNA and PET-oriented Therapy in Patients With DLBCL A Multicenter, Open-label, Phase II Trial. PHASE2 Within this exploratory multicohort phase II trial, SAKK aims to evaluate a...
Show More Status
Active Not Recruiting
Location
Ospedale Papa Giovanni XXIII
Learn More & Join Trial
Interim FDG PET/CT in Diffuse Large B Cell Lymphoma (DLBCL) Patients NA Newly diagnosed diffuse large B cell lymphoma (DLBCL) patients who enter th...
Show More Location
The Catholic University of Korea Seoul St. Mary's Hospital
Learn More & Join Trial